Table 1.
Outcome | Comparisons |
CIN2+ | Intervention vs reference group |
CIN3+ | Intervention vs reference group |
Screening participation | Intervention group: self-sampling vs GP-sampling |
Screening history | Intervention group: self-sampling vs GP-sampling |
HPV positivity rate | Intervention group: self-sampling vs GP-sampling |
HPV type distribution | Intervention group: self-sampling vs GP-sampling |
Cytology results* | Intervention group |
Compliance to follow-up among HPV positive self-samplers | Intervention group |
Proportion and results of cervical cytology samples | Reference group |
Colposcopies and conizations | Intervention vs reference group |
Cervical cancer incidence | Intervention vs reference group |
*Only available for women with an HPV positive GP-sample or GP-triage sample following an HPV positive self-sample.
CIN2+, CIN2, CIN3/AIS and cancer; CIN3+, CIN3/AIS and cancer; GP, general practitioner; HPV, human papillomavirus.